Arcus Biosciences, Inc. (RCUS)
21.98
-0.01
(-0.05%)
USD |
NYSE |
Dec 19, 16:00
21.97
-0.01
(-0.05%)
After-Hours: 20:00
Arcus Biosciences Shareholders Equity (Annual): 485.00M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Gilead Sciences, Inc. | 19.33B |
| Actinium Pharmaceuticals, Inc. | 32.76M |
| Apyx Medical Corp. | 14.21M |
| Merck & Co., Inc. | 46.31B |
| Karyopharm Therapeutics, Inc. | -186.02M |